Answers are grounded in this paper and cite their sources.
Preclinical lineage-tracing study reveals that airway secretory-derived p63+ progenitors regenerate alveolar epithelial cells after sterile injury, highlighting potential regenerative therapy targets.
Lung injury activates epithelial stem or progenitor cells for alveolar repair and regeneration. However, the origin and fate of injury-induced progenitors are poorly defined. Here, we report that p63-expressing progenitors emerge upon bleomycin-induced lung injury. These p63 + progenitors proliferate rapidly and differentiate into alveolar type 1 (AT1) and type 2 (AT2) cells through distinct trajectories. Dual recombinase-mediated sequential genetic lineage tracing reveals that p63 + progenitors originate from airway secretory cells and subsequently generate alveolar cells. Functionally, p63 activation is required for efficient alveolar regeneration from secretory cells. Our study identifies a secretory cell-derived p63 + progenitor that contributes to alveolar repair, indicating a potential therapeutic avenue for lung regeneration after injury.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: